These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 19233988)

  • 1. Transparent and reproducible reports of economic evaluations of clinical pharmacy services: a goal for the future?
    Hoffman JM; Meek PD; Touchette DR; Vermeulen LC; Schumock GT
    Am J Health Syst Pharm; 2009 Mar; 66(5):442-3; author reply 443-4. PubMed ID: 19233988
    [No Abstract]   [Full Text] [Related]  

  • 2. Economic effects of clinical pharmacy interventions: a literature review.
    De Rijdt T; Willems L; Simoens S
    Am J Health Syst Pharm; 2008 Jun; 65(12):1161-72. PubMed ID: 18541687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Where does high-quality research in economic evaluation come from?
    Zhang JX
    Pharmacotherapy; 2009 Jan; 29(1):1-2. PubMed ID: 19113791
    [No Abstract]   [Full Text] [Related]  

  • 4. A proposed model for conducting institutional-specific cost-effectiveness analysis: a case study of lipid-lowering agents.
    Hakim Z; Pierson JF; Pathak DS
    Pharm Pract Manag Q; 1996 Apr; 16(1):79-97. PubMed ID: 10157744
    [No Abstract]   [Full Text] [Related]  

  • 5. Economic Evaluation of Hospital and Community Pharmacy Services.
    Gammie T; Vogler S; Babar ZU
    Ann Pharmacother; 2017 Jan; 51(1):54-65. PubMed ID: 27586430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation and justification of clinical pharmacy services.
    Anderson SV; Schumock GT
    Expert Rev Pharmacoecon Outcomes Res; 2009 Dec; 9(6):539-45. PubMed ID: 19941431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Economic evaluations of clinical pharmacy services in China: a systematic review.
    Mi X; Su X; Jin Z; Zeng L; Li Z; Wang X; Zhang P; Zuo Y
    BMJ Open; 2020 Jan; 10(1):e034862. PubMed ID: 31911528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Economic aspects of pharmacokinetic services.
    Destache CJ
    Pharmacoeconomics; 1993 Jun; 3(6):433-6. PubMed ID: 10146877
    [No Abstract]   [Full Text] [Related]  

  • 9. A review of cost-benefit and cost-effectiveness analyses of clinical pharmacy services.
    MacKeigan LD; Bootman JL
    J Pharm Mark Manage; 1988; 2(3):63-84. PubMed ID: 10312728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determining the differences among cost savings, cost avoidance, and cost reduction.
    Howard KB; Pathak DS
    Pharm Pract Manag Q; 1999 Oct; 19(3):1-7. PubMed ID: 10747680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of cost-benefit analysis in justifying clinical pharmacy services.
    McGhan WF; Bootman JL
    Top Hosp Pharm Manage; 1984 Feb; 3(4):60-72. PubMed ID: 10314057
    [No Abstract]   [Full Text] [Related]  

  • 12. Economic evaluations of clinical pharmacy services--1988-1995. The Publications Committee of the American College of Clinical Pharmacy.
    Schumock GT; Meek PD; Ploetz PA; Vermeulen LC
    Pharmacotherapy; 1996; 16(6):1188-208. PubMed ID: 8947994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monetary valuation of benefits of pharmacy services.
    Reardon G; Pathak DS
    Top Hosp Pharm Manage; 1988 Aug; 8(2):66-75. PubMed ID: 10314296
    [No Abstract]   [Full Text] [Related]  

  • 14. Cost benefit and cost effectiveness analysis: a bibliography for pharmacists.
    Lunik MC; Segal R
    Hosp Pharm; 1986 Nov; 21(11):1072-5. PubMed ID: 10311748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Economic evaluations of clinical pharmacy services: 2006-2010.
    Touchette DR; Doloresco F; Suda KJ; Perez A; Turner S; Jalundhwala Y; Tangonan MC; Hoffman JM
    Pharmacotherapy; 2014 Aug; 34(8):771-93. PubMed ID: 24644086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pharmacoeconomics studies in specialized care: the principles, methods and practical applications].
    Soto Alvarez J
    An Med Interna; 1999 Jan; 16(1):41-6. PubMed ID: 10089651
    [No Abstract]   [Full Text] [Related]  

  • 17. ACCP: economic evaluations of clinical pharmacy services: 2001-2005.
    Perez A; Doloresco F; Hoffman JM; Meek PD; Touchette DR; Vermeulen LC; Schumock GT;
    Pharmacotherapy; 2009 Jan; 29(1):128. PubMed ID: 19113803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What Was, Is No More: Community Pharmacy Economics.
    Nightengale B
    J Manag Care Spec Pharm; 2020 Jun; 26(6):703-705. PubMed ID: 32463771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Using pharmaceutical cost analyses for decision making.
    U'Ren NA
    Hosp Cost Manag Account; 1997 Nov; 9(8):1-7. PubMed ID: 10178832
    [No Abstract]   [Full Text] [Related]  

  • 20. Efficacy and cost-containment in hospital pharmacotherapy: state of the art and future directions.
    Soumerai SB; Avorn J
    Milbank Mem Fund Q Health Soc; 1984; 62(3):447-74. PubMed ID: 6433223
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.